Provided by Tiger Fintech (Singapore) Pte. Ltd.

LISATA THERAPEUTICS INC

2.40
-0.0800-3.23%
Volume:14.45K
Turnover:35.66K
Market Cap:20.18M
PE:-1.00
High:2.51
Open:2.49
Low:2.40
Close:2.48
Loading ...

Company Profile

Company Name:
LISATA THERAPEUTICS INC
Exchange:
NASDAQ
Establishment Date:
1980
Employees:
26
Office Location:
110 Allen Road,2nd Floor,Basking Ridge,New Jersey,United States
Zip Code:
07920
Fax:
- -
Introduction:
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Directors

Name
Position
David J. Mazzo
Director and Chief Executive Officer
Gregory B. Brown
Chairman of the Board and Director
Cynthia L. Flowers
Director
Erkki Ruoslahti
Director
Heidi Henson
Director
Mohammad Azab
Director
Steven M. Klosk
Director

Shareholders

Name
Position
David J. Mazzo
Director and Chief Executive Officer
Kristen K. Buck
Executive Vice President of Research & Development and Chief Medical Officer